ProMIS Neurosciences Inc PMN

Aduhelm stimulation

[M101]

Hope this tidbit didn't interrupt Gene's video circle jerk* this morning: 

https://endpts.com/cms-to-restrict-coverage-of-biogens-controversial-alzheimers-drug-to-only-clinical-trials/

* 

ProMIS Neurosciences to Participate in the Biotech Showcase 2022 Virtual Panel Discussion: Aduhelm Stimulating the Next Generation of Alzheimer’s Treatment

 

[M101]

A chance for Gene to finally do the right thing, pump Promis and differentiate from Biogen's shoot-the-messenger (if bribes don't work) strategy!  https://endpts.com/biogen-president-fears-cms-will-finalize-restrictive-coverage-decision-for-aduhelm-preps-plans-to-flood-ncd-with-comments/

[azzymaa]

Hi m101, can you please elaborate as to what this means going forward? Is it a good buy now or wait? 

[M101]

There's no short term downside right now so it's a good bet to bounce back to .18, the pre-tax-loss value before any news, and there's no risky lab news coming this year. But there's a huge cheap warrant financing share overhang which you can see coming back to the market every morning. And given the creation of that the quality of management remains debatable. Many here also don

[M101]

btw, I assume you've looked at this week's conference presentation, so if you understood it you should be asking wtf is holding this back? Gene mentions Acumen, the financing there alone shows how ridiculously undervalued PMN is given the claimed advantages we have.   https://www.promisneurosciences.com/news-media/events/detail/8684/h-c-wainwright-bioconnect-2022-virtual

[Jumpinjackfast]

Yes , it's a 3 way stop sign with this USELESS company what is true answer probably the best was from Mackie in 2019 after Biogen stopped clinical trials exact wording was WASTE OF INVESTORS MONEY , and that PMN 310 would probably never make it to clinical trials , and look where we are at . Partnerships on the other Best In Class talk , the company this management team worked at Sanofi

[M101]

Yes but follow the money, it's incompetence and greed but not a scam because Gene and Elliot would make lot more by letting the price rise. I think Elliot's final financing was the breaking point for some insiders, leading to the FSG purchase. And since then we've seen constant market buying leading to millions accumulated under Fidelity, which begs the question is there battle for